10th July 2019
BioExcel Accelerator programme at NUI Galway is open to applications from med-tech entrepreneurs
An Tánaiste and Minister for Business, Enterprise and Innovation, Frances Fitzgerald T.D., announced the launch of the BioExel Accelerator programme at NUI Galway, supported by Enterprise Ireland, to further enhance the medical technology sector start-up ecosystem within Ireland and attract global talent to the Galway region. Though supported also by Enterprise Ireland, the BioExcel Accelerator is a new programme at the National University of Ireland, Galway (NUI Galway), which is an Associate Partner of EIT Health.
The BioExcel Accelerator programme is open to applications from potential teams or individuals both in Ireland and overseas, working in the medical technology sector. There are up to 14 slots available within the Enterprise Ireland supported Accelerator Programme over two cohorts with the first to commence later this year.
Successful applicants of the BioExel Accelerator programme will receive membership and a place within NUI Galway for a period of six months, where teams will be able to build and commercially validate their technologies by working with existing entrepreneurial networks and mentors.
Announcing the launch of the BioExel Accelerator programme while on an Enterprise Ireland and IDA Multi Sectoral Trade Mission in Singapore, An Tánaiste and Minister for Business, Enterprise and Innovation, Frances Fitzgerald T.D., said: “Ireland is recognised as a key hub for medical technology and innovation and the launch of this new accelerator is an opportunity to further build on our strong international reputation for excellence and innovation in healthcare and medtech. The Accelerator programme located at NUI Galway and supported by my Department through Enterprise Ireland will further enhance the High Potential Start-up (HPSU) eco-system and develop start-up capability, infrastructure and capital investment within the Galway region. We are delighted to support the initiative, which will go towards sustaining Ireland’s status as a global leader in medical technology innovation.”
You can read more here
NALA.care joins forces with La Roche-Posay
Discover how the partnership will benefit patients
Leuko closes €5M Series A round
Learn more about Leuko and its achievements
EIT Health appoints three new Supervisory Board members
Join us in welcoming our new Board members